Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Xinyuan Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0610-783X; OpenAlex author ID A5100670339. Sources: OpenAlex.

Their work

Papers
15 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2021: 5 papers · 2022: 3 papers · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers · 2026: 2 papers

Papers 15

  1. RNF187 neddylation in pancreatic cancer activates malignancy via IQGAP1-dependent actin cytoskeleton rearrangement. First author DOI 10.1038/s41388-025-03639-y↗
  2. Tumour-infiltrating adipocyte-derived 12,13-DiHOME subverts CD8+ T cell immunity in pancreatic ductal adenocarcinoma by promoting PPARγ-mediated ferritinophagy… Co-author DOI 10.1136/gutjnl-2025-337119↗
  3. Pancreatic cancer-derived extracellular vesicles enhance chemoresistance by delivering KRAS G12D protein to cancer-associated fibroblasts. Co-author DOI 10.1016/j.ymthe.2025.01.023↗
  4. Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer. Co-author DOI 10.1038/s41467-025-63146-2↗
  5. Deciphering extracellular vesicles protein cargo in pancreatic cancer. Co-author DOI 10.1016/j.bbcan.2024.189142↗
  6. KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer. Co-author DOI 10.1038/s41419-023-05679-2↗
  7. USP33 promotes pancreatic cancer malignant phenotype through the regulation of TGFBR2/TGFβ signaling pathway. Co-author DOI 10.1038/s41419-023-05871-4↗
  8. LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2. Co-author DOI 10.1038/s41419-022-05172-2↗
  9. Dynamic regulation of KIF15 phosphorylation and acetylation promotes focal adhesions disassembly in pancreatic cancer. Co-author DOI 10.1038/s41419-022-05338-y↗
  10. The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer. Co-author DOI 10.1038/s41420-022-01061-x↗
  11. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer. Co-author DOI 10.1038/s41419-021-03921-3↗
  12. CircRNF13 Promotes the Malignant Progression of Pancreatic Cancer through Targeting miR-139-5p/IGF1R Axis. Co-author DOI 10.1155/2021/6945046↗
  13. [6]-Paradol suppresses proliferation and metastases of pancreatic cancer by decreasing EGFR and inactivating PI3K/AKT signaling. Co-author DOI 10.1186/s12935-021-02118-0↗
  14. CircSEC24A upregulates TGFBR2 expression to accelerate pancreatic cancer proliferation and migration via sponging to miR-606. Co-author DOI 10.1186/s12935-021-02392-y↗
  15. Hypoxia-Induced ZWINT Mediates Pancreatic Cancer Proliferation by Interacting With p53/p21. Co-author DOI 10.3389/fcell.2021.682131↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianxin Jiang · 10 shared papers, 2021–2023 · strength 1.80
  2. Xueyi Jiang · 7 shared papers, 2021–2022 · strength 1.12
  3. Jian Xu · 6 shared papers, 2021–2023 · strength 1.06
  4. Yankun Chen · 5 shared papers, 2021 · strength 0.76
  5. Tingbo Liang · 3 shared papers, 2024–2025 · strength 0.70
  6. Xueli Bai · 3 shared papers, 2024–2025 · strength 0.70
  7. Jichuan Xu · 3 shared papers, 2022–2023 · strength 0.68
  8. Zhiwei He · 4 shared papers, 2021–2022 · strength 0.59
  9. Yifan Hong · 2 shared papers, 2024–2025 · strength 0.51
  10. Gang Quan · 2 shared papers, 2022–2023 · strength 0.39
  11. Jie Wang · 2 shared papers, 2021 · strength 0.28
  12. Peng Chen · 2 shared papers, 2021 · strength 0.28
  13. Chengxiao Yang · 1 shared paper, 2026 · strength 0.28
  14. Bei Sun · 1 shared paper, 2026 · strength 0.28
  15. Chundong Cheng · 1 shared paper, 2026 · strength 0.28
  16. Xuewei Bai · 1 shared paper, 2026 · strength 0.28
  17. Wenbo Yang · 1 shared paper, 2026 · strength 0.28
  18. Hongze Chen · 1 shared paper, 2026 · strength 0.28
  19. Jiaqi Yang · 1 shared paper, 2025 · strength 0.26
  20. Jie Wang · 1 shared paper, 2023 · strength 0.22
  21. X W Bai · 1 shared paper, 2026 · strength 0.22
  22. Yan Luo · 1 shared paper, 2026 · strength 0.22
  23. Guanqun Li · 1 shared paper, 2026 · strength 0.22
  24. Rui Kong · 1 shared paper, 2026 · strength 0.22
  25. Yingmei Zhang · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.